Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00185848 · ClinicalTrials.gov registry record · Phase 1

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

A Phase 1 study, sponsored by Sanjiv Sam Gambhir.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target

NCT00185848: Completed Phase 1 study, sponsored by Sanjiv Sam Gambhir.

NCT00185848 is a Phase 1 study that has completed, run by Sanjiv Sam Gambhir. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00185848, a Phase 1 study, has completed, sponsored by Sanjiv Sam Gambhir.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether \[18F\]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase 1 study we will assess the safety and biodistribution of \[18F\]FHBG in patients.

Interventions

  • RADIATION [18F]FHBG

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2005-04
Est. Completion 2013-06
Phase Phase 1
Sanjiv Sam Gambhir

3 total trials

What the finished NCT00185848 record still lists

NCT00185848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which [18F]FHBG is the first listed.

NCT00185848 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00185848 about?

NCT00185848 is a clinical study titled "Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis". The purpose of this study is to determine whether \[18F\]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase 1 study we will assess the safety and biodistribution of \[18F\]FHBG in patients.

What is the current status of trial NCT00185848?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2005-04. Estimated completion is 2013-06.

What interventions are being tested in trial NCT00185848?

The interventions under investigation include: [18F]FHBG (RADIATION).

Who is sponsoring clinical trial NCT00185848?

This trial is sponsored by Sanjiv Sam Gambhir, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00185848's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00185848, the US trial registry maintained by the National Library of Medicine. NCT00185848 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.